These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14748439)

  • 41. Significance of anti-glomerular basement membrane antibodies in type 2 diabetic patients.
    Noorwali A
    Saudi Med J; 2005 Nov; 26(11):1734-6. PubMed ID: 16311657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased peripheral blood mitochondrial DNA in type 2 diabetic patients with nephropathy.
    Malik AN; Shahni R; Iqbal MM
    Diabetes Res Clin Pract; 2009 Nov; 86(2):e22-4. PubMed ID: 19660820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production of superoxide and nitric oxide by granulocytes in non-insulin-dependent diabetic patients with and without diabetic nephropathy.
    Kedziora-Kornatowska KZ
    IUBMB Life; 1999 Sep; 48(3):359-62. PubMed ID: 10690652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients.
    Ramakrishna V; Jailkhani R
    Acta Diabetol; 2008 Mar; 45(1):41-6. PubMed ID: 17924055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes.
    Haidara MA; Mikhailidis DP; Rateb MA; Ahmed ZA; Yassin HZ; Ibrahim IM; Rashed LA
    J Diabetes Complications; 2009; 23(2):130-6. PubMed ID: 18436458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
    Lazarevic G; Antic S; Vlahovic P; Djordjevic V; Zvezdanovic L; Stefanovic V
    Ren Fail; 2007; 29(2):199-205. PubMed ID: 17365936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy.
    Koshimura J; Fujita H; Narita T; Shimotomai T; Hosoba M; Yoshioka N; Kakei M; Fujishima H; Ito S
    Biochem Biophys Res Commun; 2004 Mar; 316(1):165-9. PubMed ID: 15003525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetics of diabetic nephropathy in type 2 DM: candidate gene analysis for the pathogenic role of inflammation.
    Lee SH; Lee TW; Ihm CG; Kim MJ; Woo JT; Chung JH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S32-6. PubMed ID: 16174285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-18 contributes more closely to the progression of diabetic nephropathy than other diabetic complications.
    Fujita T; Ogihara N; Kamura Y; Satomura A; Fuke Y; Shimizu C; Wada Y; Matsumoto K
    Acta Diabetol; 2012 Apr; 49(2):111-7. PubMed ID: 20186552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytokines profile and its correlation with endothelial damage and oxidative stress in patients with type 1 diabetes mellitus and nephropathy.
    Pestana RM; Domingueti CP; Duarte RC; Fóscolo RB; Reis JS; Rodrigues AM; Martins LB; Sousa LP; Lage DP; Ferreira CN; Ferreira AV; Fernandes AP; Gomes KB
    Immunol Res; 2016 Aug; 64(4):951-60. PubMed ID: 27307060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy.
    Shikano M; Sobajima H; Yoshikawa H; Toba T; Kushimoto H; Katsumata H; Tomita M; Kawashima S
    Nephron; 2000 May; 85(1):81-5. PubMed ID: 10773760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy.
    Fujita T; Shimizu C; Fuke Y; Satomura A; Abe M; Kaizu K; Matsumoto K; Soma M
    Diabetes Res Clin Pract; 2011 Jun; 92(3):e66-9. PubMed ID: 21440322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased Expression of Circulating Stress Markers, Inflammatory Cytokines and Decreased Antioxidant Level in Diabetic Nephropathy.
    Mansoor G; Tahir M; Maqbool T; Abbasi SQ; Hadi F; Shakoori TA; Akhtar S; Rafiq M; Ashraf M; Ullah I
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363561
    [No Abstract]   [Full Text] [Related]  

  • 54. [Progress in diagnosis and treatment of renal diseases. II. Nephropathies associated with systemic diseases. Diabetic nephropathy with NIDDM].
    Yajima Y
    Nihon Naika Gakkai Zasshi; 1996 Oct; 85(10):1650-6. PubMed ID: 8999056
    [No Abstract]   [Full Text] [Related]  

  • 55. [The role of IL-6 in the development of morphological changes in renal tissue in elderly patients with type 2 diabetes complicated by diabetic nephropathy].
    Rakitianskaia IA; Riabov SI; Dubrova AG; Azanchevskaia SV; Riabova TS; Gurkov AS
    Adv Gerontol; 2012; 25(4):632-7. PubMed ID: 23734508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB.
    Hofmann MA; Schiekofer S; Isermann B; Kanitz M; Henkels M; Joswig M; Treusch A; Morcos M; Weiss T; Borcea V; Abdel Khalek AK; Amiral J; Tritschler H; Ritz E; Wahl P; Ziegler R; Bierhaus A; Nawroth PP
    Diabetologia; 1999 Feb; 42(2):222-32. PubMed ID: 10064103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activity of Group 2 Innate Lymphoid Cells is Associated with Chronic Inflammation and Dysregulated Metabolic Homoeostasis in Type 2 Diabetic Nephropathy.
    Lu P; Ji X; Wan J; Xu H
    Scand J Immunol; 2018 Feb; 87(2):99-107. PubMed ID: 29194733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated Levels of Protein Carbonylation in Patients With Diabetic Nephropathy: Therapeutic and Diagnostic Prospects.
    Almogbel E; Rasheed N
    Am J Med Sci; 2019 Jul; 358(1):26-32. PubMed ID: 31076070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Type 2 diabetes, nephropathy and HLA.
    Thompson CF
    N Z Med J; 1999 Feb; 112(1081):41. PubMed ID: 10078216
    [No Abstract]   [Full Text] [Related]  

  • 60. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.
    Pickup JC; Mattock MB; Chusney GD; Burt D
    Diabetologia; 1997 Nov; 40(11):1286-92. PubMed ID: 9389420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.